OT - *Feels* like CIEN wants to bust upwards. That would sure be nice going into options writing season on the stock.

ISRG beat on revs and earnings - the beta is crazy - Should've grabbed more the last time it dipped below $500. China is a concern, given their expansion plans. But I believe

the majority of prostate surgery in the US is now done with the help of their Da Vinci robotic guided system, and I haven't seen any competitors (or, really, competitors to come,

from Medtronics and J and J's Jansen Pharmaseutical Division) that are targeting that particular space. I read that AH it hit $553, but the last trade now shows at $545. Nicely

above $500, in any case.